<DOC>
	<DOCNO>NCT00935818</DOCNO>
	<brief_summary>This study provide opportunity combine varenicline bupropion SR capitalize potential additive benefit . The investigator hypothesize increase long-term ( ≥ 6 month ) smoke abstinence rate .</brief_summary>
	<brief_title>Varenicline Bupropion Smoking Cessation</brief_title>
	<detailed_description>Cigarette smoke single important preventable cause morbidity , mortality excess health care cost United States account 30 % U.S. cancer death . Varenicline bupropion SR ( sustained-release ) non nicotine pharmacotherapies FDA-indicated treatment tobacco dependence cigarette smoker . Although varenicline proven great efficacy bupropion SR , medication associate high end-of-treatment smoking abstinence rate . However , almost two-thirds smoker treat varenicline report smoke 6 month . Because varenicline bupropion SR different mechanism action different neuropharmacologic target , combination pharmacotherapy agent may increase long-term smoking abstinence rate observe single-agent therapy . In recent pilot study combination therapy varenicline bupropion SR , observe treatment well-tolerated 7-day point prevalence smoking abstinence rate 71 % ( 95 % CI : 54-85 % ) 3 month 58 % ( 95 % CI : 41-74 % ) 6 month . Determining efficacy combination therapy compare single-agent therapy immediate important clinical implication . In study , conduct randomize , multicenter , control clinical trial evaluate efficacy combination therapy varenicline bupropion SR compare varenicline placebo 506 cigarette smoker Mayo Clinic Rochester , MN , University Minnesota Minneapolis , MN .</detailed_description>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>1 . Subject least 18 year age ; 2 . Subject provide write informed consent ; 3 . Subject smoking great equal 10 cigarette per day least 6 month ; 3 ) Subject able complete study visit 4 ) Subject good health determine investigator 5 ) Subject ability participate fully aspects study keep scheduled appointment 6 ) Subject motivate stop smoking . Female pregnant , lactate likely become pregnant trial able willing use contraception : 1. unstable medical condition ; 2. another household member participate study ; 3. bupropion varenicline allergy ; 4. current use ( previous 30 day ) tobacco dependence treatment unable unwilling discontinue use ; 5. unstable medical condition unstable angina , myocardial infarction , coronary angioplasty ( past 3 month ) untreated cardiac dysrhythmia ; 6. history renal failure renal dialysis ; 7. history seizure ; 8. define CSSRS ( ColumbiaSuicide Severity Rating Scale ) , current nonspecific suicidal thought lifetime history suicidal attempt ( define `` potentially selfinjurious act commit least wish die , result act '' ) ; 9. history close head trauma associate &gt; 30 minute loss consciousness , amnesia , skull fracture , subdural hematoma , brain contusion ; 10. history psychosis , bipolar disorder , bulimia anorexia nervosa ; 11. current moderate severe depression assess score ≥ 20 Beck Depression Inventory , Second Edition ( BDIII ) 10 ; 12. active substance abuse nicotine ; 13. current ( past 14 day ) use antipsychotic , monoamine oxidase inhibitor , drug know interact bupropion SR ; 14. recent dose change antidepressant ( within last 3 month ) ; 15. untreated hypertension baseline systolic blood pressure &gt; 180 diastolic &gt; 100 ; 16. current treatment another investigational drug tobacco dependence ( previous 30 day ) ; 17. current use bupropion varenicline ( previous 30 day ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>smoking</keyword>
	<keyword>nicotine</keyword>
	<keyword>tobacco</keyword>
	<keyword>dependence</keyword>
	<keyword>cessation</keyword>
	<keyword>abstinence</keyword>
</DOC>